Español 
Deutsch 
Français 
MSCI World Index (MSC)
NASDAQ Composite (NASDAQ)
FTSE China A50 Index (FGI)
STOXX Europe 600 (SIX)
Nikkei 300 (OSA)
NIFTY 50 (NSE)
DAX Performance Index (XETRA)
FTSE 100 (FGI)
CAC 40 (EURONEXT)
China Petrochemical Development Corporation (1314.TW)
Kaohsiung, TW
China Petrochemical Development Corporation (CPDC), along with its subsidiaries, is a Taiwanese enterprise primarily engaged in the manufacturing and global distribution of petrochemical intermediates. Its core product range includes engineering plastics, synthetic resins, and chemical fibers. The company's extensive portfolio features petroleum, alkali-chlorine, and phosphoric acid derivatives. It also provides comprehensive supply chain services, encompassing the storage, transportation, procurement, and sale of various chemicals and raw materials, including forging items. Key products offered include caprolactam (a precursor for nylon-6 fibers and resins), acrylonitrile (used in acrylic fibers and ABS plastic), and various grades of nylon chips (for fiber, engineering plastic, and film applications). Other significant industrial chemicals include ammonium sulfate (an agricultural fertilizer), hydrogen cyanide (a raw material for MMA production), and refined sulfuric acid, which serves diverse sectors such as batteries, electronics, telecommunications, and national defense. CPDC also supplies O-Phenylphenol for downstream industrial uses. Beyond its chemical operations, CPDC has diversified interests. These include real estate investment and development, the construction of petrochemical support facilities, and general engineering and construction contracting. The company is also active in biotechnology and pharmaceutical research, development, and marketing, as well as managing the storage, transport, procurement, and sales of fertilizers. Furthermore, CPDC is involved in trading a wide array of products such as petrochemicals, electronic chemicals, industrial gases, and gas mixtures. Its service offerings extend to water treatment, plumbing, apparatus and instrument installation, refrigeration and air conditioning engineering, tank car repair, and mechanical engineering, in addition to supplying dicalcium phosphate. The corporation also commissions the building of residential and commercial properties, operates plant rental services, and manages land development projects and various other investment ventures. Founded in 1969, China Petrochemical Development Corporation maintains its headquarters in Kaohsiung, Taiwan.
No mergers or acquisitions recorded for this company.
| Indicator | 1D | 1W | 2W | 3W | 1M |
|---|
Day Score & sub-scores
Statistical fingerprint & regime detail
Conditional historical analysis
Customize analysis (advanced)
| 1D | 5D | 1M | 3M | 6M | YTD | 1Y | 3Y | 5Y | 10Y | Max |
|---|---|---|---|---|---|---|---|---|---|---|
| +1.64% | -4.34% | -11.30% | -16.81% | -21.94% | -12.10% | -6.57% | -30.87% | -39.82% | -3.61% | -33.61% |
Revenue flow
Revenue by geography
Revenue by segment
Revenue composition
By product
By geography
Income Statement
Balance Sheet
Cash Flow Statement
Key Metrics
Financial Ratios
Employees
Financial Growth (CAGR)
Market Data
DCF figures are point estimates: small changes in growth or discount-rate assumptions move them materially. Read them as a reference, not a precise target.
| Rating | 2024-11 | Change |
|---|---|---|
| Strong Buy | 1 | 0 |
| Buy | 1 | 0 |
| Hold | 4 | 0 |
| Sell | 0 | 0 |
| Strong Sell | 0 | 0 |
-
Revenue growth Chemicals - Specialty: +4.7%-34.7% Q1'26: -37.2% (vs Q1'25)
-
EPS growth Chemicals - Specialty: +13.2%-1,292.7% Q1'26: +14.4% (vs Q1'25)
-
FCF margin FCF growth · Chemicals - Specialty: +44.1%-23.3% Q1'26: +15.7% (vs Q1'25)
-
EBIT margin Chemicals - Specialty: +8.8%-18.6% Q1'26: -15.8% (vs Q1'25)
-
ROIC Chemicals - Specialty: +5.6%-3.1% Q1'26: -2.3% (vs Q1'25)
-
Share dilution Chemicals - Specialty: +0.1%+0.4% Q1'26: 0.0% (vs Q1'25)
-
Debt / EBITDA Net debt/EBITDA · Chemicals - Specialty: 0.18×-17.61× Q1'26: -32.46× (vs Q1'25)
* These projections are based on analyst consensus estimates and user-defined valuation multiples. This table is for informational purposes only and does not constitute a recommendation to buy or sell any security. Past performance is not indicative of future results.
| Metric |
Dec 2015 actual |
Dec 2016 actual |
Dec 2017 actual |
Dec 2018 actual |
Dec 2019 actual |
Dec 2020 actual |
Dec 2021 actual |
Dec 2022 actual |
Dec 2023 actual |
Dec 2024 actual |
|---|---|---|---|---|---|---|---|---|---|---|
| Revenue |
26.16B
est: 29.36B (-10.9%)
|
25.38B
est: 25.38B (0.0%)
|
33.34B
est: 33.15B (+0.6%)
|
38.50B
est: 38.50B (+0.0%)
|
29.62B
est: 31.68B (-6.5%)
|
17.58B
est: 17.59B (0.0%)
|
35.16B
est: 24.19B (+45.4%)
|
25.03B
est: 25.07B (-0.2%)
|
26.41B
est: 16.53B (+59.8%)
|
29.44B
est: 28.07B (+4.9%)
|
| EBITDA |
1.32B
est: 2.57B (-48.5%)
|
189.85M
est: 2.22B (-91.5%)
|
7.74B
est: 2.90B (+166.7%)
|
6.14B
est: 3.37B (+82.2%)
|
2.22B
est: 2.77B (-20.0%)
|
460.27M
est: 1.54B (-70.1%)
|
6.16B
est: 2.12B (+190.8%)
|
2.34B
est: 2.19B (+6.4%)
|
1.56B
est: 1.45B (+8.1%)
|
2.47B
est: 1.64B (+50.5%)
|
| EBIT |
-1.79B
est: 1.15B (-255.3%)
|
-1.58B
est: 998.29M (-257.8%)
|
3.58B
est: 1.30B (+174.8%)
|
3.08B
est: 1.51B (+103.0%)
|
2.00B
est: 1.25B (+60.8%)
|
325.48M
est: 691.74M (-52.9%)
|
4.20B
est: 951.59M (+341.6%)
|
1.18B
est: 986.17M (+19.6%)
|
127.15M
est: 650.24M (-80.4%)
|
1.10B
est: 231.47M (+375.2%)
|
| Net Income |
95.53M
est: 603.79M (-84.2%)
|
-1.87B
est: -2.29B (+18.4%)
|
6.09B
est: 8.03B (-24.1%)
|
4.29B
est: 5.65B (-24.0%)
|
1.74B
est: 1.98B (-12.0%)
|
680.99M
est: 447.52M (+52.2%)
|
3.49B
est: 3.32B (+5.2%)
|
233.11M
est: -1.25B (+118.7%)
|
-1.06B
est: 3.07B (-134.6%)
|
247.68M
est: 3.69B (-93.3%)
|
| SGA |
1.13B
est: 2.07B (-45.1%)
|
1.11B
est: 1.79B (-38.0%)
|
1.55B
est: 2.33B (-33.5%)
|
1.77B
est: 2.71B (-34.8%)
|
1.63B
est: 2.23B (-26.7%)
|
1.41B
est: 1.24B (+13.8%)
|
2.12B
est: 1.70B (+24.4%)
|
2.20B
est: 1.76B (+24.6%)
|
1.75B
est: 1.16B (+50.1%)
|
1.70B
est: 1.96B (-13.6%)
|
| EPS |
0.04
est: 0.16 (-76.5%)
|
-0.76
est: -0.61 (-25.6%)
|
2.39
est: 2.12 (+12.7%)
|
1.57
est: 1.49 (+5.3%)
|
0.60
est: 0.52 (+14.9%)
|
0.20
est: 0.12 (+69.2%)
|
1.06
est: 0.88 (+20.9%)
|
0.06
est: -0.33 (+118.7%)
|
-0.28
est: 0.81 (-134.6%)
|
0.07
est: 0.97 (-93.3%)
|
| Date | Rating | Overall | DCF | ROE | ROA | D/E | P/E | P/B |
|---|---|---|---|---|---|---|---|---|
| 2026-05-11 | C | 2/5 | 1/5 | 1/5 | 1/5 | 1/5 | 1/5 | 5/5 |
| 2026-05-08 | C | 2/5 | 1/5 | 1/5 | 1/5 | 1/5 | 1/5 | 5/5 |
| 2026-05-07 | C | 2/5 | 1/5 | 1/5 | 1/5 | 1/5 | 1/5 | 5/5 |
| 2026-05-06 | C | 2/5 | 1/5 | 1/5 | 1/5 | 1/5 | 1/5 | 5/5 |
| 2026-05-05 | C | 2/5 | 1/5 | 1/5 | 1/5 | 1/5 | 1/5 | 5/5 |
| 2026-05-04 | C | 2/5 | 1/5 | 1/5 | 1/5 | 1/5 | 1/5 | 5/5 |
| 2026-04-30 | C | 2/5 | 1/5 | 1/5 | 1/5 | 1/5 | 1/5 | 5/5 |
| 2026-04-29 | C | 2/5 | 1/5 | 1/5 | 1/5 | 1/5 | 1/5 | 5/5 |
| 2026-04-28 | C | 2/5 | 1/5 | 1/5 | 1/5 | 1/5 | 1/5 | 5/5 |
| 2026-04-27 | C | 2/5 | 1/5 | 1/5 | 1/5 | 1/5 | 1/5 | 5/5 |
| 2026-04-24 | C | 2/5 | 1/5 | 1/5 | 1/5 | 1/5 | 1/5 | 5/5 |
| 2026-04-23 | C | 2/5 | 1/5 | 1/5 | 1/5 | 1/5 | 1/5 | 5/5 |
| 2026-04-22 | C | 2/5 | 1/5 | 1/5 | 1/5 | 1/5 | 1/5 | 5/5 |
| 2026-04-21 | C | 2/5 | 1/5 | 1/5 | 1/5 | 1/5 | 1/5 | 5/5 |
| 2026-04-20 | C | 2/5 | 1/5 | 1/5 | 1/5 | 1/5 | 1/5 | 5/5 |
| 2026-04-17 | C | 2/5 | 1/5 | 1/5 | 1/5 | 1/5 | 1/5 | 5/5 |
| 2026-04-16 | C | 2/5 | 1/5 | 1/5 | 1/5 | 1/5 | 1/5 | 5/5 |
Owner Earnings
Ownership Overview
Ownership breakdown not available.
No beneficial ownership filings recorded.
Institutional Activity (13F)
Institutional history not available.
Top holders not available.
ETF Ownership
| # | ETF | Weight | Est. AUM exposure | TER |
|---|---|---|---|---|
| 1 | FlexShares Morningstar Emerging Markets Factor Tilt Index Fund TLTE | 0.11% | 382.0K | 0.58% |
| 2 | iShares MSCI AC Far East ex-Japan Small Cap UCITS ETF ISFE.L | 0.09% | 63.8K | 0.74% |
| 3 | State Street SPDR S&P Emerging Markets Small Cap ETF EWX | 0.08% | 545.7K | 0.65% |
| 4 | State Street SPDR MSCI Emerging Markets Small Cap UCITS ETF EMSD.L | 0.07% | 424.0K | 0.55% |
| 5 | iShares MSCI Emerging Markets Small-Cap ETF EEMS | 0.07% | 263.9K | 0.72% |
| 6 | Avantis Emerging Markets Small Cap Equity ETF AVEE | 0.07% | 79.9K | 0.42% |
| 7 | iShares MSCI EM Small Cap UCITS ETF IEMS.L | 0.06% | 191.2K | 0.74% |
| 8 | Vanguard FTSE All-World ex-US Small-Cap ETF VSS | 0.02% | 2.72M | 0.06% |
| 9 | Avantis Emerging Markets ex-China Equity ETF AVXC | 0.01% | 54.1K | 0.33% |
| 10 | Avantis Emerging Markets Equity UCITS ETF USD Acc AVEM.L | 0.01% | 23.7K | 0.35% |
Insider Activity
No insider activity available.
Insider history not available.
No recent insider transactions.
Executive team
Executive compensation
Executive compensation not available.
No CEO compensation history available.
Proxy statements
No proxy statements available for this company yet.
Recent SEC filings
No SEC filings available for this company yet.
Executive team
| Name | Title | Compensation | Gender |
|---|---|---|---|
| Ching-Jing Sheen | Chief Consultant | 5M | male |
| Chi-Tsung Kao | Acting Vice President of Petrochemical Production Dept., Assistant VP of Engineering Tech. Office & Plant Chief | — | male |
| Donald Tsou | Vice President | — | male |
| Hong-Long Chen | Plant Chief | — | male |
| Ying-Chun Chen | GM, Company Secretary, Chief of Accounting & Finance Department | — | male |
| Yu-Ping Zhou | Chief Internal Auditor | — | — |
No data available for this company.
No Senate trading activity found for this company.
No House trading activity found for this company.
Share your view on this stock and instantly see how the community has voted over the last 6 months.
Community Opinion for 1314.TW
Short-term intention
Target Price Distribution
These are community opinions and do not constitute buy or sell advice to act on. The results shown are based on aggregated opinions and are not an investment recommendation, nor do they intend to influence any investment decision.
